FRANKLIN, WI, UNITED STATES, October17, 2024 /EINPresswire.com/ — TigerAesthetics Medical, LLC, a division of Tiger BioSciences, is pleased to announce the acquisition ofselect assets from Suneva Medical, Inc., an innovative medical technology company pioneeringregenerative aesthetics. This strategic acquisition is set to further strengthen Tiger Aesthetics’market presence in regenerative aesthetics and complements the company’s upcoming adiposecell and tissue products, alloClae™ and dermaClae™.
The acquisition immediately brings additional manufacturing capabilities and three new productlines to Tiger Aesthetics: BellaFill®biostimulatory dermal filler, Silhouette Instalift®andAmplifine™ PRP. With these additional products and assets from Suneva, Tiger Aesthetics ispositioned as a leader in regenerative aesthetics, with a portfolio backed by scientific and clinicalbreakthroughs.
“With this acquisition, we continue to bring together unique clinical applications and revenuestreams that help our customers grow their practices,” said Oliver Burckhardt, Co-CEO of TigerBioSciences. “The addition of these products marks a significant step toward our goal ofbecoming a leader in both facial and full body aesthetics.”
Tiger Aesthetics continues to deliver one of the most comprehensive aesthetics portfolios,supported by world class customer service, training and practice development to ensure successwith all of its partner providers.
“All across the world, there is growing demand for regenerative treatments that deliver naturaland impactful results,” said Pat Altavilla, CEO of Suneva Medical. “Through the acquisition ofSuneva Medical assets, Tiger Aesthetics will be able to offer an even larger portfolio of products,partner with more cosmetic providers, and bring Suneva Medical’s expertise in commercializingmarket defining products to strategic regions globally.”
About Suneva Medical, Inc.Suneva Medical, Inc., headquartered in San Diego, CA, is a leader in regenerative aesthetics. It isfocused on developing, manufacturing and commercializing branded products for providers andtheir patients. Suneva Medical offers a portfolio of products to address the impact of the agingprocess to deliver solutions that leverage the body’s own restorative capacity. The productportfolio is composed of several “only” and “first to market” solutions with both FDA PMAapproval and 510(k) clearance. For more information, visit www.sunevamedical.com.
About Tiger Aesthetics Medical, LLC.Tiger Aesthetics, headquartered in Franklin, WI, is committed to delivering new, cutting-edgeproducts that meet the evolving needs of aesthetic practitioners and their patients. Built on aheritage of human cell & tissue processing expertise and focused on three primary clinical areas– reconstruction, cosmetic and regenerative – Tiger Aesthetics enables practitioners to providelife-changing results for a wide range of patients. These innovative technologies and productsrepresent a unique opportunity for innovation to advance the field of Aesthetic Medicine.
The Tiger Aesthetics portfolio includes HSC/HSC+ silicone gel breast implants, AlloX2®andDermaspan tissue expanders, and the Viality™ fat transfer system. In 2025, the company willlaunch two innovative adipose cell and tissue products, alloClae and dermaClae, which willprovide groundbreaking new treatment options for aesthetic practitioners and their patients. Formore information, visit www.tiger-aesthetics.com.
Eddie Carden
Tiger Aesthetics Medical, LLC
206-618-4279
email us here
Visit us on social media:
LinkedIn
Instagram
This press release can be viewed online at: https://www.einpresswire.com/article/751683673EIN
Presswire’s priority is source transparency. We do not allow opaque clients, and our editorstry to be careful about weeding out false and misleading content. As a user, if you see somethingwe have missed, please do bring it to our attention. Your help is welcome. EIN Presswire,Everyone’s Internet News Presswire™, tries to define some of the boundaries that are reasonablein today’s world. Please see our Editorial Guidelines for more information.
© 1995-2024 Newsmatics Inc. All Right Reserved.